Clinical Reports

Monopolar radiofrequency treatment of human eyelids: A prospective, multicenter, efficacy trial

  1. Brian S. Biesman MD, FACS1,†,*,
  2. Sterling S. Baker MD2,†,
  3. Jean Carruthers MD, FRCS(C), FRC(Ophth)3,‡,
  4. Hector Leal Silva MD4,§,
  5. Erin L. Holloman MD5,¶

Article first published online: 12 DEC 2006

DOI: 10.1002/lsm.20452

Issue

Lasers in Surgery and Medicine

Lasers in Surgery and Medicine

Volume 38, Issue 10, pages 890–898, December 2006

Additional Information

How to Cite

Biesman, B. S., Baker, S. S., Carruthers, J., Silva, H. L. and Holloman, E. L. (2006), Monopolar radiofrequency treatment of human eyelids: A prospective, multicenter, efficacy trial. Lasers in Surgery and Medicine, 38: 890–898. doi: 10.1002/lsm.20452

Author Information

  1. 1

    Department of Ophthalmology, Otolaryngology, Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee

  2. 2

    Department of Ophthalmology, Adjunct Clinical Professor Dermatology, College of Medicine of the University of Oklahoma, Oklahoma City, Oklahoma

  3. 3

    Department of Ophthalmology, University of British Columbia, Vancouver, Canada

  4. 4

    UltraLaser, SA, Monterrey, Mexico

  5. 5

    Cimarron Eye Center, Oklahoma City, Oklahoma

  1. †

    Assistant Clinical Professor.

  2. ‡

    Fellow American Society of Ophthalmic Plastic and Reconstructive Surgery, Diplomate of the American Board of Cosmetic Surgery.

  3. §

    Clinical Professor.

  4. Founder and Director General.

*345 23rd Avenue North, Suite 416, Nashville, TN 37203.

Publication History

  1. Issue published online: 12 DEC 2006
  2. Article first published online: 12 DEC 2006
  3. Manuscript Accepted: 29 SEP 2006

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (266K)

Keywords:

  • monopolar radiofrequency;
  • eyelid;
  • tissue;
  • tightening

Abstract

Background/Objective

To evaluate the efficacy of a novel 0.25 cm2 monopolar radiofrequency (RF) treatment tip for aesthetic rejuvenation of the eyelids.

Study Design/Materials and Methods

This was a prospective, multicenter trial in which the eyelids of 72 patients were treated. Patients underwent a single treatment session and were then followed on a serial basis for 6 months. Cutaneous anesthesia was not required to perform the treatments. Assessments were made by the treating physician, the subjects, and by masked physician observers evaluating photographs taken at each data point.

Results

Upper eyelid tightening and reduction of hooding was noted in 88 and 86% of subjects, respectively. Lower eyelid tightening was noted in 71–74% of subjects. The majority of patients treated achieved at least up to 25% improvement while a smaller percentage achieved more dramatic results. There was no correlation between the amount of energy applied to the eyelids and the clinical outcome. There were no serious adverse sequelae.

Conclusion

Human eyelids can be safely treated with monopolar RF energy delivered via a novel 0.25 cm2 treatment tip. Using this technology non-invasive eyelid rejuvenation was achieved in the majority of subjects treated. The factors differentiating those patients who achieve the most impressive changes from others remain unclear. Further development and testing of this technology is warranted. Lasers Surg. Med. 38:890–898, 2006. © 2006 Wiley-Liss, Inc.

Get PDF (266K)